Pfizer Seeks FDA Approval For Three Covid Vaccine Doses For Children Below Five

  • Partners Pfizer, Inc PFE and BioNTech SE BNTX urged the FDA to authorize three vaccine doses for children below five, the Wall Street Journal reports.
  • The companies previously asserted that three doses of the shot were 80% effective at preventing symptomatic Covid-19 with robust immune response in children between six months to five years.
  • After mixed results in the children who received two doses, the companies studied three doses to determine the relative efficacy of an extra dose. The FDA also postponed its review to wait for additional testing.
  • The latest Pfizer-BioNTech study results were pending peer-review by independent experts or published in a medical journal.
  • The Food and Drug Administration also weighed a request from Moderna, Inc MRNA to authorize two doses of its vaccine for children below six.
  • The FDA has scheduled meetings of outside medical advisers on June 14-15 to discuss data and review the applications from Pfizer-BioNTech's and Moderna's vaccine trials in young children.
  • The FDA clearance could come before the end of June. 
  • U.S.'s last remaining group of people, or the 19 million young children, would get access to the vaccine on clearance from the Centers for Disease Control and Prevention.
  • Price Action: PFE shares traded lower by 0.71% at $52 in the premarket on the last check Thursday.
  • Photo by x3 from Pixabay

Posted In: BriefsGovernmentNewsRegulationsMedia

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.